The Trump administration has struck a deal worth $375 million with Eli Lilly to produce 300,000 doses of an experimental antibody drug. According to The Hill: The Trump administration will pay Eli Lilly $375 million to supply 300,000 doses of its experimental antibody drug to treat COVID-19, the Department of Health and Human Services said